1003492000: Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug)

• SNOMED CT Concept\Pharmaceutical / biologic product\Medicinal product\...
• \Medicinal product categorised by disposition\Immunomodulator-containing product\Mitotic inhibitor-containing product\Microtubule inhibitor-containing product\Brentuximab vedotin-containing product\...
• \Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial
• \Brentuximab vedotin only product\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial
• \Medicinal product categorised by structure\Nitrogen and/or nitrogen compound-containing product\Polypeptide-containing product\Protein-containing product\Antibody-containing product\Monoclonal antibody-containing product\Monoclonal antibody antineoplastic agent\Brentuximab vedotin-containing product\...
• \Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial
• \Brentuximab vedotin only product\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial
• \Medicinal product categorised by therapeutic role\Antineoplastic agent\Monoclonal antibody antineoplastic agent\Brentuximab vedotin-containing product\...
• \Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial
• \Brentuximab vedotin only product\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial
• \Product manufactured as parenteral dose form\Brentuximab vedotin-containing product in parenteral dose form\Brentuximab vedotin only product in parenteral dose form\Brentuximab vedotin 50 mg powder for solution for infusion and/or injection vial\Brentuximab vedotin 50 mg powder for solution for infusion vial

Status: current, Defined. Date: 31-Jan 2021. Module: SNOMED CT core

Descriptions:

Id	Description	Lang	Type	Status	Case?	Module
4168404014	Product containing precisely brentuximab vedotin 50 milligram/1 vial powder for conventional release solution for infusion (clinical drug)	en	Fully specified name	Active	Case insensitive	SNOMED CT core
4168405010	Brentuximab vedotin 50 mg powder for solution for infusion vial	en	Synonym	Active	Case insensitive	SNOMED CT core

Expanded Value Set

This concept is not in any reference sets

Back to Start